Human Aldolase B ELISA
ALDOB (Aldolase, Fructose-Bisphosphate B) is a is roughly 250 amino acids in length that are tightly wound into two alpha helices joined by an extended strand of random coils which link the folds together. ALDOB belongs to family 15 of glycosyltransferases and transfers one N-acetylglucosamine residue from UDP-N-acetylglucosamine onto an acceptor substrate, typically Gal-type oligosaccharides. blood cells, lymphocytes, monocytes, bile duct epithelium, adrenal cortex glandular cells, placenta tissue during pregnancy stages 35, renal cell carcinoma tissues. Diseases associated with ALDOB include DiGeorge Syndrome, Hyperaldosteronism Primary, and Thrombocytopenia.
|Human Aldolase B ELISA Kit
|ALDB, ALDOB, Liver type aldolase
|Sandwich ELISA, Double Antibody
|This immunoassay kit allows for the in vitro quantitative determination of Human Aldolase B concentrations in serum plasma and other biological fluids.
|4°C for 6 months
|For Research Use Only
|Matrices listed below were spiked with certain level of Human Aldolase B and the recovery rates were calculated by comparing the measured value to the expected amount of Human Aldolase B in samples. Enquire for more information.
|The linearity of the kit was assayed by testing samples spiked with appropriate concentration of Human Aldolase B and their serial dilutions. The results were demonstrated by the percentage of calculated concentration to the expected. Enquire for more information.
|ELISA Microplate (Dismountable)
|4°C for 6 months
|Sample/Standard Dilution Buffer
|4°C (Protect from light)
|Antibody Dilution Buffer
|4°C (Protect from light)
|SABC Dilution Buffer
|4°C (Protect from light)
Other materials and equipment required:
- Microplate reader with 450 nm wavelength filter
- Multichannel Pipette, Pipette, microcentrifuge tubes and disposable pipette tips
- Deionized or distilled water
- Absorbent paper
- Buffer resevoir
|UniProt Protein Function:
|ALDOB: Defects in ALDOB are the cause of hereditary fructose intolerance (HFI). HFI is an autosomal recessive disease that results in an inability to metabolize fructose and related sugars. Complete exclusion of fructose results in dramatic recovery; however, if not treated properly, HFI subjects suffer episodes of hypoglycemia, general ill condition, and risk of death the remainder of life. Belongs to the class I fructose-bisphosphate aldolase family.
|UniProt Protein Details:
|Protein type:Carbohydrate Metabolism - fructose and mannose; Carbohydrate Metabolism - glycolysis and gluconeogenesis; Carbohydrate Metabolism - pentose phosphate pathway; EC 184.108.40.206; Lyase
Chromosomal Location of Human Ortholog: 9q21.3-q22.2
Cellular Component: microtubule organizing center; cytosol
Molecular Function:identical protein binding; protein binding; cytoskeletal protein binding; fructose-bisphosphate aldolase activity; ATPase binding
Biological Process: fructose 1,6-bisphosphate metabolic process; NADH oxidation; glycolysis; positive regulation of ATPase activity; carbohydrate metabolic process; glucose metabolic process; pathogenesis; fructose catabolic process; gluconeogenesis; fructose metabolic process
Disease: Fructose Intolerance, Hereditary
|Fructose-1,6-bisphosphate aldolase (EC 220.127.116.11) is a tetrameric glycolytic enzyme that catalyzes the reversible conversion of fructose-1,6-bisphosphate to glyceraldehyde 3-phosphate and dihydroxyacetone phosphate. Vertebrates have 3 aldolase isozymes which are distinguished by their electrophoretic and catalytic properties. Differences indicate that aldolases A, B, and C are distinct proteins, the products of a family of related 'housekeeping' genes exhibiting developmentally regulated expression of the different isozymes. The developing embryo produces aldolase A, which is produced in even greater amounts in adult muscle where it can be as much as 5% of total cellular protein. In adult liver, kidney and intestine, aldolase A expression is repressed and aldolase B is produced. In brain and other nervous tissue, aldolase A and C are expressed about equally. There is a high degree of homology between aldolase A and C. Defects in ALDOB cause hereditary fructose intolerance. [provided by RefSeq, Dec 2008]
|NCBI GenInfo Identifier:
|NCBI Gene ID:
|UniProt Secondary Accession:
|P05062,Q13741, Q13742, Q5T7D6,
|UniProt Related Accession:
|Calculated MW: 39kDaObserved MW: 39kDa
|NCBI Full Name:
|Fructose-bisphosphate aldolase B
|NCBI Synonym Full Names:
|aldolase B, fructose-bisphosphate
|NCBI Official Symbol:
|NCBI Official Synonym Symbols:
|NCBI Protein Information:
|fructose-bisphosphate aldolase B; aldolase 2; liver-type aldolase; aldolase B, fructose-bisphosphatase
|UniProt Protein Name:
|Fructose-bisphosphate aldolase B
|UniProt Synonym Protein Names:
|UniProt Gene Name:
|UniProt Entry Name:
*Note: Protocols are specific to each batch/lot. For the correct instructions please follow the protocol included in your kit.
Before adding to wells, equilibrate the SABC working solution and TMB substrate for at least 30 min at 37°C. When diluting samples and reagents, they must be mixed completely and evenly. It is recommended to plot a standard curve for each test.
|Set standard, test sample and control (zero) wells on the pre-coated plate respectively, and then, record their positions. It is recommended to measure each standard and sample in duplicate. Wash plate 2 times before adding standard, sample and control (zero) wells!
|Aliquot 0.1ml standard solutions into the standard wells.
|Add 0.1 ml of Sample / Standard dilution buffer into the control (zero) well.
|Add 0.1 ml of properly diluted sample ( Human serum, plasma, tissue homogenates and other biological fluids.) into test sample wells.
|Seal the plate with a cover and incubate at 37 °C for 90 min.
|Remove the cover and discard the plate content, clap the plate on the absorbent filter papers or other absorbent material. Do NOT let the wells completely dry at any time. Wash plate X2.
|Add 0.1 ml of Biotin- detection antibody working solution into the above wells (standard, test sample & zero wells). Add the solution at the bottom of each well without touching the side wall.
|Seal the plate with a cover and incubate at 37°C for 60 min.
|Remove the cover, and wash plate 3 times with Wash buffer. Let wash buffer rest in wells for 1 min between each wash.
|Add 0.1 ml of SABC working solution into each well, cover the plate and incubate at 37°C for 30 min.
|Remove the cover and wash plate 5 times with Wash buffer, and each time let the wash buffer stay in the wells for 1-2 min.
|Add 90 µl of TMB substrate into each well, cover the plate and incubate at 37°C in dark within 10-20 min. (Note: This incubation time is for reference use only, the optimal time should be determined by end user.) And the shades of blue can be seen in the first 3-4 wells (with most concentrated standard solutions), the other wells show no obvious color.
|Add 50 µl of Stop solution into each well and mix thoroughly. The color changes into yellow immediately.
|Read the O.D. absorbance at 450 nm in a microplate reader immediately after adding the stop solution.
When carrying out an ELISA assay it is important to prepare your samples in order to achieve the best possible results. Below we have a list of procedures for the preparation of samples for different sample types.
|If using serum separator tubes, allow samples to clot for 30 minutes at room temperature. Centrifuge for 10 minutes at 1,000x g. Collect the serum fraction and assay promptly or aliquot and store the samples at -80°C. Avoid multiple freeze-thaw cycles.
If serum separator tubes are not being used, allow samples to clot overnight at 2-8°C. Centrifuge for 10 minutes at 1,000x g. Remove serum and assay promptly or aliquot and store the samples at -80°C. Avoid multiple freeze-thaw cycles.
|Collect plasma using EDTA or heparin as an anticoagulant. Centrifuge samples at 4°C for 15 mins at 1000 × g within 30 mins of collection. Collect the plasma fraction and assay promptly or aliquot and store the samples at -80°C. Avoid multiple freeze-thaw cycles. Note: Over haemolysed samples are not suitable for use with this kit.
|Urine & Cerebrospinal Fluid
|Collect the urine (mid-stream) in a sterile container, centrifuge for 20 mins at 2000-3000 rpm. Remove supernatant and assay immediately. If any precipitation is detected, repeat the centrifugation step. A similar protocol can be used for cerebrospinal fluid.
|Cell culture supernatant
|Collect the cell culture media by pipette, followed by centrifugation at 4°C for 20 mins at 1500 rpm. Collect the clear supernatant and assay immediately.
|Solubilize cells in lysis buffer and allow to sit on ice for 30 minutes. Centrifuge tubes at 14,000 x g for 5 minutes to remove insoluble material. Aliquot the supernatant into a new tube and discard the remaining whole cell extract. Quantify total protein concentration using a total protein assay. Assay immediately or aliquot and store at ≤ -20 °C.
|The preparation of tissue homogenates will vary depending upon tissue type. Rinse tissue with 1X PBS to remove excess blood & homogenize in 20ml of 1X PBS (including protease inhibitors) and store overnight at ≤ -20°C. Two freeze-thaw cycles are required to break the cell membranes. To further disrupt the cell membranes you can sonicate the samples. Centrifuge homogenates for 5 mins at 5000xg. Remove the supernatant and assay immediately or aliquot and store at -20°C or -80°C.
|Rinse tissue with PBS, cut into 1-2 mm pieces, and homogenize with a tissue homogenizer in PBS. Add an equal volume of RIPA buffer containing protease inhibitors and lyse tissues at room temperature for 30 minutes with gentle agitation. Centrifuge to remove debris. Quantify total protein concentration using a total protein assay. Assay immediately or aliquot and store at ≤ -20 °C.
|Collect milk samples and centrifuge at 10,000 x g for 60 min at 4°C. Aliquot the supernatant and assay. For long term use, store samples at -80°C. Minimize freeze/thaw cycles.
|Elseweidy et al.
|Ellagic acid ameliorates high fructose-induced hyperuricemia and non-alcoholic fatty liver in Wistar rats: Focusing on the role of C1q/tumor necrosis factor-related protein-3 and ATP citrate lyase
|Life Sciences 2022
Fill out our quote form below and a dedicated member of staff will get back to you within one working day!